Earnings Call · Q4 FY2021·2022-03-25

Q4 21EPS 0.00%·Rev n/aQ3 21EPS +7.14%·Rev n/aQ2 21EPS +6.67%·Rev n/aQ1 21EPS 0.00%·Rev n/a⚠ consensus missing

ADMA BIOLOGICS, INC. ADMA

Skyler Bloom — Investor Relations

Adam Grossman — President and Chief Executive Officer

Brian Lenz — Executive Vice President, Chief Financial Officer

+3.6%1d on move date+4.7% vs SPY3d+5.8%5d+7.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADMA calls or request research access.

More ADMA calls Browse calls Request research access